Sign In
Buy KDMN
$9.50
+0 (+0%)
At Close: Aug 17, 2022
Kadmon to Present at the Raymond James 2020 Virtual Human Health Innovation Conference
12:00pm, Thursday, 11'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 11, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Raymond James 2020
Jun 08, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Tyrosine Kinase Inhibitor Market”...
Hedge Funds Aren’t Done Buying Kadmon Holdings, Inc. (KDMN)
06:22am, Monday, 08'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Kadmon Raises $50 Million in Gross Proceeds Through Its at-the-Market Facility
08:15pm, Friday, 05'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 5, 2020 / Kadmon Holdings, Inc. (KDMN) today announced that it has raised gross proceeds of $50.0 million through its At-The-Market (ATM) facility, including participa
3 “Strong Buy” Biotech Stocks Under $5 With Major Catalysts Approaching
01:56pm, Monday, 01'st Jun 2020
Optimism is on the rise, and investors are wondering if stocks are heading towards recovery territory. So, what does this mean for one industry that has largely outperformed the broader market amid th
7 Cheap Stocks to Buy With Great Potential
12:50pm, Wednesday, 27'th May 2020
In times of market turbulence, cheap stocks offer a unique way to escape the broad moves up and down and instead benefit from big potential.
Kadmon to Present at the Jefferies 2020 Virtual Global Healthcare Conference
12:00pm, Wednesday, 27'th May 2020
NEW YORK, NY / ACCESSWIRE / May 27, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced that Harlan W. Waksal, M.D., President and Chief Executive Officer, will present at the Jefferies 2020 Virt
Why Kadmon Holdings Jumped Today
05:35pm, Thursday, 21'st May 2020
The company reported positive results from a clinical trial for one of its most promising pipeline candidates.
Kadmon sees positive results in study on pill for graft-versus-host disease
11:30am, Thursday, 21'st May 2020
The New York-based biotech said it intends to submit to the Food and Drug Administration in October, taking advantage of an agency pilot program.
Kadmon Announces Positive Topline Results of Pivotal Trial of Belumosudil (KD025) in Chronic Graft-Versus-Host Disease
11:25am, Thursday, 21'st May 2020
NEW YORK, NY / ACCESSWIRE / May 21, 2020 / Kadmon Holdings, Inc. (KDMN) today announced positive topline results from the primary analysis of ROCKstar (KD025-213), the pivotal trial evaluating belumos
7 Biotech Stocks Wall Street Says Will Double or More
08:08pm, Tuesday, 19'th May 2020
Bull market or bear market, one fact remains unwavering: Biotech stocks represent the ultimate risk/reward plays.These investments are inherently volatile in nature. Numerous biotechnology companies h
H.C. Wainwright Sticks to Their Buy Rating for Kadmon Holdings
10:52am, Monday, 11'th May 2020
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Kadmon Holdings (NYSE:KDMN) on Monday, setting a price target of $25, which is approximately 470.78% above the present share price of $4.
Analysts Have Lowered Expectations For Kadmon Holdings, Inc. (NYSE:KDMN) After Its Latest Results
02:50pm, Sunday, 10'th May 2020
Shareholders of Kadmon Holdings, Inc. (NYSE:KDMN) will be pleased this week, given that the stock price is up 10% to...
Kadmon Provides Business Update and Reports First Quarter 2020 Financial Results
08:14pm, Thursday, 07'th May 2020
NEW YORK, NY / ACCESSWIRE / May 7, 2020 / Kadmon Holdings, Inc. (NYSE:KDMN) today provided a business update and reported financial and operational results for the first quarter of 2020. "We made ...
Bank of New York Mellon Corp Acquires 120,507 Shares of Kadmon Holdings Inc (NYSE:KDMN)
09:06am, Monday, 20'th Apr 2020
Bank of New York Mellon Corp grew its holdings in Kadmon Holdings Inc (NYSE:KDMN) by 27.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm own
